The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
When it came to putting resting for recovery into practice, my inner critics all jumped on the mic, interrupting logic with their words of wisdom. If you take a rest day, youll get fat If youre not training, then youre not growing Someone is training while youre resting Youll never be good enough Im sure youve heard these same things before, likely from your own self-critiquing voices
Understanding how each medication functions, its effectiveness, potential side effects, and suitability is crucial for choosing the right treatment plan
Ozan Erdogan and Bilal Gl